6.79
+0.41
(6.51%)
Real-time:
12:18pm BST
LON real-time data - Disclaimer
Currency in GBX unless noted
| Range | 6.25 - 6.79 |
| 52 week | 2.50 - 7.00 |
| Open | 6.38 |
| Vol / Avg. | 150,000.00/37,680.00 |
| Mkt cap | 7.19M* |
| P/E | - |
| Div/yield | - |
| EPS | -0.05* |
| Shares | 105.92M |
| Beta | - |
| Inst. own | - |
| *GBP |
Key stats and ratios
| Q2 (Jun '12) | 2011 | |
| Net profit margin | -643.15% | -38.04% |
| Operating margin | -644.06% | -36.04% |
| EBITD margin | - | -32.59% |
| Return on average assets | -259.80% | -79.92% |
| Return on average equity | - | - |
| Employees | 23 | - |
| Carbon Disclosure Rating | - | - |
Address
Suite 275, 5151 McCrimmon Parkway
MORRISVILLE, NC 27560
United States - Map
+1-919-4154300 (Phone)
+1-302-6555049 (Fax)
MORRISVILLE, NC 27560
United States - Map
+1-919-4154300 (Phone)
+1-302-6555049 (Fax)
Website links
External links
Analyst Estimates - BusinessWeek
Options - MarketWatch
Research Reports - Reuters
Director Dealings - Yahoo Finance
Discussion Group - Google Finance
Advertisement
Description
TyraTech, Inc. is a natural life sciences company that develops insect and parasite control solutions for human and animal health. Its technology platform TyraTech Nature Technology, focuses on specific neurological receptors that are only active in insects and parasites. Its patented scientific platform identifies synergistic combinations of natural compounds. The Company has partnerships with Kraft Foods and the Terminix International Company, L.P. It partners with Terminix to develop, manufacture and market ready-to-use pest control products featuring TyraTech Nature�s Technology. It also develops natural solutions to control head lice and to repel mosquitoes, ticks and other pests, and internal and external parasite control solutions for household pets, horses and cattle.
Officers and directors
| Bruno Georges Jactel | Chief Executive Officer, Executive Director | |
| Peter K. Jerome | Chief Financial Officer, Group Secretary | |
| Shayne M. Wetherall | Vice President - Commercial Operations | |
| Keith Kennedy Ph.D. | Vice President - Product Development | |
| Alan John Reade | Non-Executive Chairman of the Board | |
| Kevin Thomas Schultz Ph.D. | Non-Executive Director | |
| James R. Hills | Non-Executive Independent Director | |
| Barrington Marshall Riley | Senior Non-Executive Independent Director |